Oncotarget

Research Papers:

Systematic analysis of molecular mechanisms for HCC metastasis via text mining approach

PDF |  HTML  |  How to cite

Oncotarget. 2017; 8:13909-13916. https://doi.org/10.18632/oncotarget.14692

Metrics: PDF 2556 views  |   HTML 1854 views  |   ?  

Cheng Zhen, Caizhong Zhu, Haoyang Chen, Yiru Xiong, Junyuan Tan, Dong Chen and Jin Li _

Abstract

Cheng Zhen1, Caizhong Zhu1, Haoyang Chen1, Yiru Xiong1, Junyuan Tan1, Dong Chen1, Jin Li1

1Beijing 302 Hospital, Beijing, 100039, China

Correspondence to:

Jin Li, email: [email protected]

Keywords: hepatocellular carcinoma, metastasis, text mining

Received: April 05, 2016     Accepted: January 03, 2017     Published: January 17, 2017

ABSTRACT

Objective: To systematically explore the molecular mechanism for hepatocellular carcinoma (HCC) metastasis and identify regulatory genes with text mining methods.

Results: Genes with highest frequencies and significant pathways related to HCC metastasis were listed. A handful of proteins such as EGFR, MDM2, TP53 and APP, were identified as hub nodes in PPI (protein-protein interaction) network. Compared with unique genes for HBV-HCCs, genes particular to HCV-HCCs were less, but may participate in more extensive signaling processes. VEGFA, PI3KCA, MAPK1, MMP9 and other genes may play important roles in multiple phenotypes of metastasis.

Materials and methods: Genes in abstracts of HCC-metastasis literatures were identified. Word frequency analysis, KEGG pathway and PPI network analysis were performed. Then co-occurrence analysis between genes and metastasis-related phenotypes were carried out.

Conclusions: Text mining is effective for revealing potential regulators or pathways, but the purpose of it should be specific, and the combination of various methods will be more useful.


INTRODUCTION

Hepatocellular carcinoma (HCC) is the second cause of death from malignancy tumor and the sixth most prevalent cancer worldwide [1]. Like many other types of malignance tumor, metastasis was considered the primary cause for treatment failure and HCC-associated mortalities [2, 3]. Understanding the molecular mechanisms involved in HCC metastasis would facilitate to develop novel strategies, such as personalized therapies and molecular-targeted drugs, which may help to improve the rate of survival.

A large number of genes and proteins have been examined for HCC metastasis. However, since metastasis is thought to be a multi-step process regulated by sophisticated molecular network, it is necessary to systematically assess the significance of each gene and find out the most important regulators.

Nowadays, text mining (TM) technology is increasingly applied for data analysis. In this study, we employed text mining technology and other bioinformatics methods to perform systematic analysis toward published articles, in order to figure out the critical genes and pathways for HCC metastasis, and to profile the unique regulations for HCCs with different etiologies such as HBV and HCV.

RESULTS

HCC metastasis-related genes and KEGG pathway analysis

According to text mining and frequency analysis, 1116 genes were identified within 8218 abstracts. The top 20 genes and their frequencies were listed in Table 1. Among these genes, VEGFA, AFP, CDH1, MMP2 and MMP9 were mentioned more than 150 times, while MAPK1, TGFB1, AKT1, CTNNB1 and other genes were also widely studied.

Table 1: The top 20 HCC metastasis-related genes based on text mining

Gene

Description

Count

VEGFA

vascular endothelial growth factor A

252

AFP

alpha fetoprotein

190

CDH1

cadherin 1 (E-cadherin)

154

MMP2

matrix metallopeptidase 2

154

MMP9

matrix metallopeptidase 9

153

MAPK1

mitogen-activated protein kinase 1

123

TGFB1

transforming growth factor beta 1

118

AKT1

AKT serine/threonine kinase 1

110

CTNNB1

catenin beta 1

100

PTK2

protein tyrosine kinase 2 (FAK)

93

SPP1

secreted phosphoprotein 1

85

NME1

NME/NM23 nucleoside diphosphate kinase 1

82

NFKB1

nuclear factor kappa B subunit 1

76

MET

MET proto-oncogene, receptor tyrosine kinase

75

BSG

basigin (CD147)

72

PIK3CA

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

71

HIF1A

hypoxia inducible factor 1 alpha subunit

68

CD44

CD44 molecule

67

FN1

fibronectin 1

65

HGF

hepatocyte growth factor

65

Only the genes that co-appeared with metastasis-related phenotypes in the same sentence will be counted. If a gene appeared several times in one sentence, it would be treated once.

KEGG pathway analysis was carried out with identified genes. The top 20 pathways were listed in Table 2, including focal adhesion, adherens junction, regulation of actin cytoskeleton, cytokine-cytokine receptor interaction and so on.

Table 2: The most significant KEGG pathways related to HCC metastasis

KEGG Pathway

Genes

P-Value

Focal adhesion

98

< 0.0001

Adherens junction

42

< 0.0001

Regulation of actin cytoskeleton

71

< 0.0001

Cytokine-cytokine receptor interaction

78

< 0.0001

MAPK signaling pathway

74

< 0.0001

Toll-like receptor signaling pathway

39

< 0.0001

Oxidative phosphorylation

1

< 0.0001

Apoptosis

32

< 0.0001

Cell cycle

31

< 0.0001

Purine metabolism

6

< 0.0001

Insulin signaling pathway

40

0.0001

Wnt signaling pathway

40

0.0002

Neuroactive ligand-receptor interaction

22

0.0002

TGF-beta signaling pathway

27

0.0002

Pyrimidine metabolism

3

0.002

Tight junction

30

0.002

Glycerophospholipid metabolism

2

0.003

Jak-STAT signaling pathway

37

0.007

Gap junction

24

0.01

Fatty acid metabolism

2

0.01

Official symbols of all 1116 genes were treated as inputs. KEGG pathways were sorted by P value.

HCC metastasis-related PPI analysis

Critical regulators usually work as hub proteins in regulation network, so the PPI network among these proteins was generated and illustrated in Figure 1. The degree of nodes (the number of proteins interacting with it) was demonstrated in Table 3. The degree of UBC (ubiquitin C) is much higher than others’, which may partly be attributed to its function in protein degradation. EGFR (degree = 157), MDM2 (degree = 153), TP53 (degree = 152), APP (degree = 149), HSP90AA1 (degree = 149) and other proteins are also predicted as core nodes among the network.

The

Figure 1: The PPI network of HCC-metastasis related genes. All edges were treated as undirected and all interactions were based on experiments. Isolated nodes and self-loops were deleted. Network was built with input nodes only, excluding their neighbours.

Table 3: The top 20 nodes in HCC metastasis-related PPI network

Node

Description

Degree

UBC

ubiquitin C

739

EGFR

epidermal growth factor receptor

157

MDM2

MDM2 proto-oncogene

153

TP53

tumor protein p53

152

APP

amyloid beta precursor protein

149

HSP90AA1

heat shock protein 90 alpha family class A member 1

149

EP300

E1A binding protein p300

135

SUMO1

small ubiquitin-like modifier 1

130

GRB2

growth factor receptor bound protein 2

128

SRC

SRC proto-oncogene, non-receptor tyrosine kinase

126

CTNNB1

catenin beta 1

125

FN1

fibronectin 1

123

YWHAZ

tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta

122

ESR1

estrogen receptor 1

110

HSP90AB1

heat shock protein 90 alpha family class B member 1

107

HDAC1

histone deacetylase 1

100

AKT1

AKT serine/threonine kinase 1

96

AR

androgen receptor

92

MAPK1

mitogen-activated protein kinase 1

88

CUL7

cullin 7

87

MYC

v-myc avian myelocytomatosis viral oncogene homolog

87

The degree of each node was calculated with CytoNCA. All edges were treated as undirected. MYC was equal with CUL7.

Metastasis of HCCs resulting from HBV or HCV

Chronic HBV or HCV infections now have been recognized as the major risk factors for the development HCC [4], but they take very different strategies for tumorigenesis. HBV DNA is integrated into the host genome and increases the HCC risk through several approaches such as increased levels of HBV proteins, transactivation of transcription factors, disruption of chromosomal stability and so on [5]. Instead, HCV has no integration into host DNA, neither direct oncogenic activity of its genes. Subsequent HCC always develops following liver fibrosis and cirrhosis [4, 6]. So HCCs caused by HBV or HCV may differ in metastasis mechanisms.

To verify this hypothesis, 286 genes were identified in Pubmed retrieves, 78 of which were shared by HBV and HCV papers, 165 particularly for HBV and 43 particularly for HCV. Genes uniquely mentioned with HBV or HCV were demonstrated in Figure 2, and their KEGG results were listed in Table 4. Besides the overlapping processes, HBV-particular genes were involved in MAPK pathway, tight junction and adherens junction. HCV-particular genes, by contrast, participated in more extensive signaling cascades, including TGF-beta, Jak-STAT, cell cycle, ECM-receptor interaction and gap junction, though the number of them was much less (43 VS 165).

Genes

Figure 2: Genes unique to HBV or HCV-related-metastasis. Genes with low frequency (freq < 5) were excluded. As papers about HCV-metastasis were less than that of HBV (136 VS 262), all frequencies of HCV particular genes were normalized based on the number of papers (×1.926).

Table 4: The KEGG pathways for HBV/HCV particular genes related to metastasis

KEGG Pathway

Genes

P-Value

For HBV Particular Genes

For HCV Particular Genes

MAPK signaling pathway

15

0.0003

Y

Tight junction

8

0.004

Y

Adherens junction

6

0.007

Y

Cytokine-cytokine receptor interaction

7

0.0003

Y

TGF-beta signaling pathway

4

0.0006

Y

ECM-receptor interaction

3

0.005

Y

Jak-STAT signaling pathway

4

0.005

Y

Gap junction

3

0.007

Y

Cell cycle

3

0.008

Y

Focal adhesion

16/5

< 0.0001/0.005

Y

Y

Regulation of actin cytoskeleton

14/5

0.0003/0.003

Y

Y

Toll-like receptor signaling pathway

7/3

0.006/0.008

Y

Y

As shown in the last two columns, pathways may belong to HBV/HCV-HCC metastasis particular genes, or shared by both.

Co-occurrence analysis with metastasis-related phenotypes

According to classical theory [7], metastasis can be roughly divided into several steps. Cancer cells have to depart from the original position, invade the extracellular matrix and enter vascular system, where they travel to other sites of body and eventually form new colonization [8, 9]. That is a real tough experience. Reasonably, if a gene can simultaneously affect more than one metastasis related phenotypes, its mutation or de-regulation is more likely to facilitate metastasis.

To identify these genes, four metastasis-related phenotypes were extracted from metastasis cascades. They were “adhesion”, “migration”, “invasion” and “angiogenesis”. The co-occurrence between these words and genes were examined, and the results were demonstrated in Figure 3. The mostly concerned phenotype was “invasion” (freq = 2786), and then “migration” (freq = 1826). “Adhesion” (freq = 696) and “angiogenesis” (freq = 561) had relatively low co-occurrence with genes. Go along with the four typical phenotypes, PTK2 (with “adhesion”, freq = 64), CDH1 (with “migration”, freq = 49), MMP9 (with “invasion”, freq = 104) and VEGFA (with “angiogenesis”, freq = 98) were the most popular genes, respectively.

The

Figure 3: The co-occurrence between genes and metastasis-related phenotypes. For each phenotype the size of circle indicated the number of genes that arise with it in one sentence. The thickness of edge reflected the frequency of each co-occurrence relationship.

To highlight the genes that may affect multiple phenotypes, genes co-occurred with 2 or more phenotypes (threshold of frequency was 7) were listed and cluster analysis was performed in Figure 4. Several genes, such as VEGFA, PI3KCA, MAPK1 and MMP9, were obviously involved in almost all steps, and they should be preferentially regarded as potential regulators for HCC metastasis.

Cluster

Figure 4: Cluster analysis for genes that co-appeared with metastasis-related phenotypes. Data were linearly normalized. Hierarchical cluster analysis was performed based on maximum-linkage, using similarity metric of Euclidean distance.

DISCUSSION

As an effective method [10], text mining has been used to explore regulation mechanism for several types of cancers, including glioblastoma [11], endometrial cancer [12], prostate cancer [13, 14], and breast cancer [15]. Actually, the relationship between gene and cancer is specific: under specific environment, through specific pathways, and affect specific processes or phenotypes of tumor biology, such as transformation, proliferation, metastasis, recurrence, drug resistance and so on. To get more valuable information, the objective of text mining should be clearly defined. For our study, we focus on “HCC metastasis”, and the relationship between genes and different steps of metastasis were calculated respectively. With specific aim and multiple methods, the association between genes and HCC metastasis could be more precisely addressed.

The etiology of HCC is another crucial issue. As mentioned above, HBV and HCV infection have different mechanisms of tumorigenesis, so they may exert different approaches for HCC metastasis. Exploration for such etiology-specific pathways may shed promise for targeted drugs and personalized treatments.

As a matter of fact, the most popular genes are not always the most important ones. Meanwhile, some other genes though crucial for HCC metastasis, may not get due attention. The purpose of our paper is not just to gather what have been done by now, but also to reveal what should be focused in the future. Genes with moderate frequency, but involved in multi-processes or interacting with principal molecules, might be fertile land for novel discoveries.

Each method used in this research has its own advantages and disadvantages. Frequency calculation is an effective method for text mining, but not enough for functional analysis. PPI network analysis is useful to find out hub regulators, but the specificity may be impaired with too much inputs. Co-occurrence analysis with phenotypes or biological functions is an improvement of word frequency analysis, where the universality of information and the specificity of the results are simultaneously emphasized, but the feature words have to be identified in advance. So these methods should be carefully selected and results should be extensively considered.

There are still some limitations in this study. First, ABNER is a biomedical entity recognition software based on statistical machine learning [16]. Although it has been optimized, not all genes will be identified. Second, it takes a long time to check gene names, symbols and alias. Third, text mining can calculate the frequencies of specific words and calculate their relationships, but they cannot actually “understand” literatures. However, text mining is still helpful for us to observe molecular biology achievements of HCC metastasis on a macro level, and quantitatively assess the roles and relationships for genes with multidimensional perspectives.

MATERIALS AND METHODS

We search PubMed with the statement (HCC OR “hepatocellular carcinoma”) AND metastasis, and 8218 literatures were found out (to June 15th, 2016). Similarly, “HBV AND (HCC OR “hepatocellular carcinoma”) AND metastasis” and “HCV AND (HCC OR “hepatocellular carcinoma”) AND metastasis” were applied to collect genes involved in HCC metastasis resulting from HBV or HCV. All abstracts were downloaded from PubMed document retrieval system. Genes and proteins among abstracts were identified with ABNER (Version 1.5) [16, 17]. Gene symbols were normalized manually based on the Entrez Gene Database. Word frequency analysis was performed with Microsoft Excel 2010. To reflect the relationship between genes and metastasis, several phenotypes were selected, such as “metastasis”, “adhesion”, “migration”, “invasion” and “angiogenesis”. Only the genes that co-appeared with these words in the same sentence will be counted. If a gene appeared several times in one sentence, it would be treated once. KEGG pathway analysis was performed on GATHER (Gene Annotation Tool to Help Explain Relationships, http://gather.genome.duke.edu/) [18], and the threshold of P is 0.05.

The protein-protein interaction (PPI) network was integrated with BisoGenet [19], and interaction data come from BIND [20, 21], BioGrid [22], DIP [23], MINT [24], IntAct [25] and HPRD [26]. All interactions were based on experiments. The PPI network was illustrated with Cytoscape (version 3.4.0) [27] and analyzed with CytoNCA [28], a plugin for Cytoscape. Co-occurrence analysis between genes and phenotypes was illustrated with Gephi (Version 0.8.2 beta) [29]. Hierarchical cluster analysis based on maximum-linkage (similarity metric with Euclidean distance) was performed with HemI (Version 1.0) [30].

CONFLICTS OF INTEREST

The authors have no conflicts of interest to declare.

REFERENCES

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015; 136:E359–386.

2. Page AJ, Cosgrove DC, Philosophe B, Pawlik TM. Hepatocellular carcinoma: diagnosis, management, and prognosis. Surgical oncology clinics of North America. 2014; 23:289–311.

3. Tang ZY. Hepatocellular carcinoma—cause, treatment and metastasis. World journal of gastroenterology. 2001; 7: 445–454.

4. Sukowati CH, El-Khobar KE, Ie SI, Anfuso B, Muljono DH, Tiribelli C. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma. World journal of gastroenterology. 2016; 22:1497–1512.

5. Ringelhan M, O'Connor T, Protzer U, Heikenwalder M. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. The Journal of pathology. 2015; 235:355–367.

6. Shirvani-Dastgerdi E, Schwartz RE, Ploss A. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Current opinion in virology. 2016; 20:1–10.

7. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006; 127:679–695.

8. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nature reviews Cancer. 2002; 2:563–572.

9. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature reviews Cancer. 2003; 3:453–458.

10. Luo Y, Riedlinger G, Szolovits P. Text mining in cancer gene and pathway prioritization. Cancer informatics. 2014; 13:69–79.

11. Natarajan J, Berrar D, Dubitzky W, Hack C, Zhang Y, DeSesa C, Van Brocklyn JR, Bremer EG. Text mining of full-text journal articles combined with gene expression analysis reveals a relationship between sphingosine-1-phosphate and invasiveness of a glioblastoma cell line. BMC bioinformatics. 2006; 7:373.

12. Gao H, Zhang Z. Systematic Analysis of Endometrial Cancer-Associated Hub Proteins Based on Text Mining. BioMed research international. 2015; 2015:615825.

13. Chun HW, Tsuruoka Y, Kim JD, Shiba R, Nagata N, Hishiki T, Tsujii J. Automatic recognition of topic-classified relations between prostate cancer and genes using MEDLINE abstracts. BMC bioinformatics. 2006; 7:S4.

14. Deng X, Geng H, Bastola DR, Ali HH. Link test—A statistical method for finding prostate cancer biomarkers. Computational biology and chemistry. 2006; 30:425–433.

15. Krallinger M LF, Valencia A. Analysis of biological processes and diseases using text mining approaches. Methods Mol Biol. 2010.

16. Settles B. ABNER: an open source tool for automatically tagging genes, proteins and other entity names in text. Bioinformatics. 2005; 21:3191–3192.

17. Settles B. Biomedical Named Entity Recognition Using Conditional Random Fields and Rich Feature Sets. Proceedings of the International Joint Workshop on Natural Language Processing in Biomedicine and its Applications. 2004:104–107.

18. Chang JT, Nevins JR. GATHER: a systems approach to interpreting genomic signatures. Bioinformatics. 2006; 22:2926–2933.

19. Martin A, Ochagavia ME, Rabasa LC, Miranda J, Fernandez-de-Cossio J, Bringas R. BisoGenet: a new tool for gene network building, visualization and analysis. BMC bioinformatics. 2010; 11:91.

20. Bader GD, Betel D, Hogue CW. BIND: the Biomolecular Interaction Network Database. Nucleic acids research. 2003; 31:248–250.

21. Willis RC, Hogue CW. Searching, viewing, and visualizing data in the Biomolecular Interaction Network Database (BIND). Current protocols in bioinformatics / editoral board, Andreas D Baxevanis [et al] 2006, Chapter 8:Unit 8 9.

22. Stark C, Breitkreutz BJ, Chatr-Aryamontri A, Boucher L, Oughtred R, Livstone MS, Nixon J, Van Auken K, Wang X, Shi X, Reguly T, Rust JM, Winter A, et al. The BioGRID Interaction Database: 2011 update. Nucleic acids research. 2011; 39:D698–704.

23. Xenarios I, Salwinski L, Duan XJ, Higney P, Kim SM, Eisenberg D. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic acids research. 2002; 30:303–305.

24. Licata L, Briganti L, Peluso D, Perfetto L, Iannuccelli M, Galeota E, Sacco F, Palma A, Nardozza AP, Santonico E, Castagnoli L, Cesareni G. MINT, the molecular interaction database: 2012 update. Nucleic acids research. 2012; 40:D857–861.

25. Aranda B, Achuthan P, Alam-Faruque Y, Armean I, Bridge A, Derow C, Feuermann M, Ghanbarian AT, Kerrien S, Khadake J, Kerssemakers J, Leroy C, Menden M, et al. The IntAct molecular interaction database in 2010. Nucleic acids research. 2010; 38:D525–531.

26. Goel R, Muthusamy B, Pandey A, Prasad TS. Human protein reference database and human proteinpedia as discovery resources for molecular biotechnology. Molecular biotechnology. 2011; 48:87–95.

27. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research. 2003; 13:2498–2504.

28. Tang Y, Li M, Wang J, Pan Y, Wu FX. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Bio Systems. 2015; 127:67–72.

29. Bastian M HS, Jacomy M. Gephi: an open source software for exploring and manipulating networks. The International AAAI Conference on Weblogs and Social Media. 2009.

30. Deng W, Wang Y, Liu Z, Cheng H, Xue Y. HemI: a toolkit for illustrating heatmaps. PloS one. 2014; 9:e111988.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14692